Drug Shortage Report for AVALIDE
| Report ID | 166530 |
| Drug Identification Number | 02241819 |
| Brand name | AVALIDE |
| Common or Proper name | Irbesartan and Hydrochlorothiazide Tablets |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Bottle of 90 tablets |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-04-19 |
| Estimated end date | 2022-09-30 |
| Actual end date | 2022-08-10 |
| Shortage status | Resolved |
| Updated date | 2022-08-11 |
| Company comments | Manufacturing Issue. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-08-11 | French | Compare |
| v1 | 2022-08-11 | English | Compare |
Showing 1 to 2 of 2